Prediction Case File
CMGstockbearishVerified Fail

Structured market prediction extracted from social analysis, normalized by AI, enriched with validation metrics, analyst reliability, live position tracking and source-level evidence.

The Patient Investor2025-11-11T00:53:00monthlyfundamental
Live Outcome
-5.06%
Performance since published
Fail
Publish Price
30.45999908
Entry captured near publish time
Current Price
-
Latest tracked market price
Target Price
28.5
Predicted objective
Invalidation
32
Risk boundary
Prediction Structure

Entry, target and invalidation logic

The original analyst prediction is converted into a structured intelligence object with price mentions, normalized direction, target distance, invalidation distance and risk/reward context.

Price Mentioned by AI
30.59
Original Analyst Trend
Bearish
AI-Detected Price Direction
Bearish
Normalized Market Direction
Bearish
Initial Target Distance
6.43%
Initial Invalidation Distance
5.06%
Risk / Reward
1.27
Timeframe
Monthly
Live Position
-5.06%
Live
Current Price
-
Live Score
-
Distance to Target Now
-
Distance to Invalidation Now
-
Price Structure Valid
No
Warning
-
Quality Breakdown

AI quality scoring

Each signal is scored for clarity, accuracy, actionability and overall usefulness before it contributes to intelligence metrics.

40%
Principal
60%
Actionable
60%
Overall
Principal40.00%
Comprehensible80.00%
Accurate60.00%
Actionable60.00%
Derived Quality60.00%
Validation & Result

What happened after publication?

The platform tracks price movement after publication and records outcome, runup, drawdown and resolution metadata.

Published
2025-11-11T00:53:00
First Checked
-
Last Checked
-
Resolved
2025-11-21T19:30:00
Resolved At
2025-11-21T19:30:00
Resolved Candle
2025-11-21T19:30:00
Max High
30.48999977
Max High At
-
Min Low
29.75
Min Low At
-
Time To Result
258.62h
Result
Fail
Validation Status
Resolved
Analyst Intelligence

Who generated this prediction?

The Patient Investor
YouTube · @thepatientinvestorr
Reliability
46.94
Success Rate
33.49%
Consistency
82.73
Risk Adjusted
-7.99
Avg Return
-1.07%
Avg Quality
3.5
Original Social Post

Source, summary and reference

Platform
YouTube
Media Type
youtube_video
Language
-
Gemini Model
-
Processed At
-
External Post ID
lJnuNvVt8Mg
Open Original Post →
AI Summary

The video discusses three stocks, CELH, ELF and CMG, trading near their 52-week lows. CELH, currently priced at $41.52, has experienced a 35% drop over the last month. The video identifies concerns about CELH's Alani Nu distribution agreement affecting revenues in the next 1-2 quarters, plus organic growth in the CELH brand only at 13% year-over-year. International growth has only grown 24%. It also mentions analyst concerns, but notes the valuation is more interesting now. For ELF, it trades at $73.74, a 40% drop over 2-3 days. It beat earnings per share expectations, despite slight miss on revenue. Guidance was disappointing due to China tariffs. Rhode acquisition should contribute 13% revenue growth forecast. The company expects sequentially gross margin improvements in the second half of the year. Rhode's expected contribution, analyst is less optimistic. ELFs organic is 3-4% currently. The CEO expects revenue of 1.55 billion to 1.57 billion. The stock needs Rhodes acquisition to hit growth for the quarters ahead. For Chipotle, it trades at $30.59 a 50% decline year to date. It slightly missed revenue and the company said consumer spending is impacting it because of spending less. They won't be doing discouting but will have menu innovation. But its core earnings is still good. Finally, the author notes that the given advice isn't financial.

Original Caption

Friends! In this video, I'm going to do an analysis of Celsius Stock, ELF Stock, and CMG Stock MY PORTFOLIO & DISCORD: https://www.patreon.com/patientinvestor MY TWITTER: https://twitter.com/patientinvestt 0:00 Celsius 4:51 Elf Beaty 9:32 Chipotle FREE ACCESS To Fiscal.AI https://fiscal.ai/?via=Patient

Signal Metadata

Scoring and consensus eligibility

These fields explain whether this prediction is already verified, whether it contributes to analyst scoring, and whether it is included in symbol target consensus.

Forward-Looking Signal
No
Verified Outcome
Yes
Included in Analyst Score
Yes
Included in Target Consensus
No
Public Listing Status
Listed
Status Explanation
-
Why Not Included in Score Yet
-
Target Consensus Exclusion
Not Forward Signal